NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice
- 3 November 2000
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 408 (1), 25-34
- https://doi.org/10.1016/s0014-2999(00)00709-3
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Is Pharmacological Neuroprotection Dependent on Reduced Glutamate Release?Stroke, 2000
- The Riluzole Early Access Programme: descriptive analysis of 844 patients in FranceZeitschrift für Neurologie, 1997
- Amyotrophic Lateral SclerosisDrugs, 1996
- Glycine site antagonists abolish dopamine D 2 but not D 1 receptor mediated catalepsy in ratsJournal of Neural Transmission, 1994
- Glutamate: its role in learning, memory, and the aging brainPsychopharmacology, 1993
- Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivoNeuroscience Letters, 1992
- The NMDA Receptor, NMDA Antagonists and Epilepsy TherapyDrugs, 1992
- Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemiaNeuroscience Letters, 1992
- The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behaviorJournal of Neural Transmission, 1992
- Ibotenic acid stimulates d-[3H]aspartate release from cultured cerebellar granule cellsNeuroscience Letters, 1989